For citations:
Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022). Rheumatology Science and Practice. 2022;60(5):609-611. (In Russ.)
Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022). Rheumatology Science and Practice. 2022;60(5):609-611. (In Russ.)